您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
嘉宾信息
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位: 党委书记、董事长、总经理
所属公司: 扬子江药业集团
个人简介:
徐浩宇:现任扬子江药业集团党委书记、董事长兼总经理,全国工商联医药业商会副会长,中国医药质量管理协会副会长,江苏省工商业联合会副会长,江苏省苏商发展促进会常务副会长,江苏省医药行业协会会长,曾荣获中国长三角十大杰出青商、全国QC优秀质量负责人、“十三五”苏商未来之星等称号。从管理者到药企掌门人,他华丽转身大刀阔斧推进改革,通过战略重构、机制创新和文化重塑,开启扬子江 “二次创业”新征程;他全力打造“化、中、生+药、医、养、食、游”双品牌战略,以“健康中国”为引领,为集团高质量发展锚定方向;他聚焦品质升级,持续守正创新,带领扬子江药业朝着世界一流制药企业迈进。Mr. Xu Haoyu is currently the Secretary of the Party Committee, Chairman and General Manager of Yangtze River Pharmaceutical Group, Vice President of All-China Federation of Industry & Commerce Medical & Pharmaceutical Industry Chamber, Vice President of China Quality Association for Pharmaceuticals, Vice President of Jiangsu Federation of Industry and Commerce, Executive Vice President of Jiangsu Sushang Development Promotion Association, and President of Jiangsu Provincial Pharmacy Association. He has been awarded as one of the Top 10 Outstanding Young Entrepreneurs in Yangtze River Delta, National QC Excellent Quality Person, and Future Star of Jiangsu Entrepreneurs in the Thirteenth Five-Year Plan., etc.From an executive to the person in charge of a pharmaceutical group, he has made a gorgeous turn to deepen reform, and to start a new journey of Yangtze River Pharmaceutical Group through strategic restructuring, mechanism innovation and cultural reshaping; he has made every effort to build dual brand strategy of “Chemical Medicines, Traditional Chinese Medicines, Biological Medicines + Medicines, Medical Care, Health Preserving, Food, Tourism” to set the direction for the Group’s high-quality development under the guidance of Healthy China; focusing on quality upgrading, upholding fundamental principles and breaking new ground, he is leading Yangtze River Pharmaceutical Group to move towards a world-class pharmaceutical enterprise.
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位: 大中华区战略与业务发展负责人
所属公司: 赛诺菲
个人简介:
杨樱博士拥有国内外医药行业20年的工作经历,横跨业务发展、战略、商业运营、咨询、药物开发和制造。目前她担任赛诺菲大中华区战略与业务发展负责人。在此岗位上,她将致力于推动赛诺菲中国业务发展,并为中国战略的制定及落地做出重要贡献。在加入赛诺菲之前,她曾就职于复星医药,担任高级副总裁兼首席商务官,负责全球业务和海外业务拓展。在复星之前,她在辉瑞工作了17年,期间担任过不同的角色。她曾领导全球团队制定和执行战略,以推动中长期投资组合、资产组合和组织发展。杨樱博士拥有复旦大学化学学士学位和美国西北大学工业工程与管理科学博士学位。Ying has 20 years of pharmaceutical industry experience, immersing in both western and China cultures, and spanning across strategy, business development, business operations, consulting, drug development and manufacturing. She currently leads Sanofi’s Greater China Strategy & Business Development team. In this role, Ying will drive the implementation of the Sanofi China Business Development and be a key contributor to the definition of the China strategy.  Prior to Sanofi, Ying worked at Fosun Pharmaceuticals as Sr. Vice President, Chief Business and Operations Officer, responsible for global business development and overseas businesses. Before Fosun, she worked in Pfizer for 17 years and served different roles. She was an executive leading global teams and matrix teams to set and execute strategies to drive mid-term to long-term growth, and development of portfolio, assets, and organization.  Ying holds a Ph.D. in Industrial Engineering & Management Sciences from Northwestern University, and a Bachelor’s degree in Chemistry from Fudan University in Shanghai.
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位: 集团副总裁
所属公司: 罗欣药业集团股份有限公司
个人简介:
沙鋆杰,罗欣药业集团股份有限公司·集团副总裁,数字化效能中心负责人,罗欣健康科技(上海)有限公司总经理。10年+创新科技产品策划、设计和研发经验,10年+企业高级管理经验,10年+大型复杂项目群管理经验,负责多家上市集团数字化转型战略整体规划、团队组建、数字化平台建设及数字化运营体系搭建,以数字化为抓手,大幅提升集团运营效率,改善管理和决策机制,推进公司营销模式、研发模式、生产模式、管理模式转型,达成集团数字化转型战略目标。Junjie Sha, Vice President of Luoxin Pharmaceutical Group Co., Ltd., Head of Digital Efficiency Center,General Manager of Luoxin Health Technology (Shanghai) Co., Ltd. 10 years + experience in planning, designing and R & D of innovative scientific and technological products, 10 years + experience in senior management of enterprises, 10 years + experience in management of large-scale complex project groups,Be responsible for the overall planning of digital transformation strategy, team formation, digital platform construction and digital operation system construction of many listed groups, focusing on digitalization, greatly improving the groups' operation efficiency, improving the management and decision-making mechanism, and promoting the transformation of company's marketing mode, R & D mode, production mode and management mode to achieve the group's strategic goal of digital transformation.
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位: 硕士生导师
所属公司: 烟台大学药学院
个人简介:
工程技术应用研究员,泰山学者产业领军人才,山东省有突出贡献中青年专家。烟台大学药学院硕士生导师及中国药科大学国际商学院硕士生校外指导老师,中国药学会医药知识产权研究专业委员会副主任委员,在医药行业工作20多年,先后承担国家“九五”攻关计划、国家863计划、“十二五”国家“重大新药创制”科技重大专项、企业专利价值研究等课题,领导团队研发了多个拥有知识产权保护的产品,积累了从研发、中试、产业化到商业化运营的全面管理经验,取得了良好的社会效益和经济效益。Researcher of engineering technology application, Taishan Industrial Experts Programme , Young and middle-aged experts with outstanding contributions in Shandong Province, Master tutor of Yantai University School of Pharmacy and off-campus tutor of master students of International Business School of China Pharmaceutical University, Deputy Chairman of the Professional Committee of Pharmaceutical Intellectual Property Research of the Chinese Pharmaceutical Association. Xue Yunli has worked in the pharmaceutical industry for more than 20 years, and she has successively undertaken the national 'Ninth Five-Year Plan', the National 863 Program, the 'Twelfth Five-Year' National 'Major New Drug Creation' major scientific and technological projects, research on the value of corporate patents, etc. Xue Yunli led the team to develop a number of products with intellectual property protection, accumulated comprehensive management experience from R&D, pilot test, industrialization to commercial operation, and achieved good social and economic benefits.
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务